The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Regulatory News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.00
Bid: 34.00
Ask: 36.00
Change: 1.50 (4.48%)
Spread: 2.00 (5.882%)
Open: 33.50
High: 36.00
Low: 33.00
Prev. Close: 33.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Shareholding

9 Mar 2017 07:00

RNS Number : 9294Y
Sareum Holdings PLC
09 March 2017
 

(AIM: SAR)

9 March 2017

SAREUM HOLDINGS PLC

("Sareum" or "the Company")

Director shareholding

Sareum announces that Dr. Stephen Parker, Sareum's Chairman, and his wife purchased 461,949 and 674,272 shares at 0.95p each respectively yesterday. These are the only shares that Dr Parker or his wife own in the Company. Dr Parker's shareholding represents 0.017% of the Company's issued share capital and Dr Parker's wife's shareholding represents 0.025% of the Company's issued share capital.

 

For further information, please contact:

Sareum Holdings plc

 

Tim Mitchell

01223 497 700

WH Ireland Limited (Nominated Adviser and Co-Broker)

Chris Fielding / Nick Prowting

020 7220 1666

Hybridan LLP (Co-Broker)

 

Claire Noyce / William Lynne

020 3764 2341/2342

The Communications Portfolio (Sareum Media enquiries)

 

Ariane ComstiveAriane.comstive@communications-portfolio.co.uk 

07785 922 354

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr. Stephen Parker

2

Reason for the notification

a)

Position/status

Chairman, Sareum Holdings plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sareum Holdings plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.025p each

 

 

GB00B02RFS12

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.95p

Dr. Stephen Parker: 461,949 shares

Susan Parker: 674,272 shares

Total: 1,136,221 shares

 

d)

Aggregated information

- Aggregated volume

- Price

 

1,136,2210.95p

e)

Date of the transaction

8 March 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHJPMMTMBTMTTR
Date   Source Headline
26th Oct 202011:00 amRNSPrice Monitoring Extension
20th Oct 20201:00 pmRNSExercise of Share Options and Director Dealings
13th Oct 20207:01 amRNSFull Year Results Investor Presentation
13th Oct 20207:00 amRNSFinal Results
12th Oct 20204:41 pmRNSSecond Price Monitoring Extn
12th Oct 20204:36 pmRNSPrice Monitoring Extension
8th Oct 20207:00 amRNSUS Patent Allowance: SDC-1802 TYK2/JAK1 Inhibitor
12th Aug 20207:00 amRNSDetails of Investor Presentation
11th Aug 20207:00 amRNSTrading Statement
29th Jul 20202:05 pmRNSSecond Price Monitoring Extn
29th Jul 20202:00 pmRNSPrice Monitoring Extension
24th Jul 20207:00 amRNSResearch Update
1st Jul 20207:00 amRNSUpdate on Deferred Salaries and Issue of Equity
3rd Jun 202011:06 amRNSSecond Price Monitoring Extn
3rd Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSSuccessful Fundraising
2nd Jun 20204:31 pmRNSPrimaryBid.com Offer
2nd Jun 20204:30 pmRNSPlacing to raise £718,500
27th May 20207:00 amRNSSareum to Present at BIO Digital 2020
1st May 20207:00 amRNSBioTrinity Presentation Available Online
28th Apr 20207:00 amRNSCompany Presentation at BioTrinity
20th Apr 202011:00 amRNSPrice Monitoring Extension
17th Apr 202011:05 amRNSSecond Price Monitoring Extn
17th Apr 202011:00 amRNSPrice Monitoring Extension
14th Apr 202011:06 amRNSSecond Price Monitoring Extn
14th Apr 202011:01 amRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSHalf-year Report
26th Mar 20207:00 amRNSGlobal Licensing of FL3+Aurora Programme
12th Mar 20207:00 amRNSPublication: new SRA737 combinations in cancer
17th Dec 20191:36 pmRNSResult of AGM
17th Dec 20197:00 amRNSAGM Statement
20th Nov 20197:00 amRNSNotice of AGM
5th Nov 201910:56 amRNSSareum notes Sierra Oncology Q3 2019 results
30th Oct 20197:00 amRNSResearch Update - SDC-1802 anti-cancer poster
17th Oct 20197:00 amRNSResearch Update - AACR-NCI-EORTC abstract
15th Oct 20197:00 amRNSFinal Results
7th Oct 20197:00 amRNSNotice of Full Year Results
27th Sep 20197:00 amRNSResearch Update - TYK2/JAK1 cancer programme
27th Aug 20197:00 amRNSTrading Statement
16th Aug 20197:00 amRNSChange of Adviser
8th Aug 20192:17 pmRNSSareum notes Sierra Q2 results
29th Jul 20194:29 pmRNSAdditional disclosure concerning Michael Owen
28th Jun 20197:00 amRNSAdditional Funds Raised
27th Jun 20191:50 pmRNSSierra seeks strategic options for SRA737
26th Jun 20197:00 amRNSSuccessful Fundraising
25th Jun 20194:31 pmRNSPrimaryBid.com Offer
25th Jun 20194:30 pmRNSPlacing to progress TYK2/JAK1 programmes
13th Jun 20197:00 amRNSPortfolio Update
3rd Jun 20194:00 pmRNSKey takeaways from SRA737 webcast at ASCO
3rd Jun 201911:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.